Text Classification of Cancer Clinical Trial Eligibility Criteria

Yumeng Yang, Soumya Jayaraj, Ethan Ludmir, Kirk Roberts

Research output: Contribution to journalArticlepeer-review

Abstract

Automatic identification of clinical trials for which a patient is eligible is complicated by the fact that trial eligibility are stated in natural language. A potential solution to this problem is to employ text classification methods for common types of eligibility criteria. In this study, we focus on seven common exclusion criteria in cancer trials: prior malignancy, human immunodeficiency virus, hepatitis B, hepatitis C, psychiatric illness, drug/substance abuse, and autoimmune illness. Our dataset consists of 764 phase III cancer trials with these exclusions annotated at the trial level. We experiment with common transformer models as well as a new pre-trained clinical trial BERT model. Our results demonstrate the feasibility of automatically classifying common exclusion criteria. Additionally, we demonstrate the value of a pre-trained language model specifically for clinical trials, which yield the highest average performance across all criteria.

Original languageEnglish (US)
Pages (from-to)1304-1313
Number of pages10
JournalAMIA ... Annual Symposium proceedings. AMIA Symposium
Volume2023
StatePublished - 2023

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Text Classification of Cancer Clinical Trial Eligibility Criteria'. Together they form a unique fingerprint.

Cite this